Vireo Growth Inc.
Datakwaliteit: 100%
VREOF
OTC
Manufacturing
Chemicals
€ 0,39
▼
€ 0,01
(-3,46%)
Marktkapitalisatie: 435,51 M
Prijs
€ 0,40
Marktkapitalisatie
435,51 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—
Quick Summary
Belangrijkste Punten
Revenue grew 49,06% annually over 5 years — strong growth
Negative free cash flow of -24,61 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 121,37%
Groei
Revenue Growth (5Y)
49,06%
Boven sectorgemiddelde (1,82%)
Revenue (1Y)170,43%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-26,46%
Boven sectorgemiddelde (-54,01%)
ROIC-0,19%
Net Margin-25,34%
Op. Margin-0,39%
Veiligheid
Debt / Equity
N/A
Current Ratio1,31
Interest CoverageN/A
Waardering
PE (TTM|NTM|2027)
-6,39 | 4,34 | 4,44
Onder sectorgemiddelde (-1,49)
P/B Ratio1,77
EV/EBITDA28,92
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1385 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1385 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -6,4 | -1,5 |
| P/B | 1,8 | 1,6 |
| ROE % | -26,5 | -54,0 |
| Net Margin % | -25,3 | -41,5 |
| Rev Growth 5Y % | 49,1 | 1,8 |
| D/E | — | 0,3 |
Koersdoel Analisten
1 analist
Buy
Huidig
€ 0,39
Koersdoel
€ 1,50
€ 1,50
€ 1,50
€ 1,50
Vooruitzicht
Forward K/W
4,34
Forward WPA
€ 0,09
WPA Groei (sch.)
+100,0%
Omzet Sch.
508,80 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2027 |
€ 0,09
€ 0,09 – € 0,09
|
508,80 M | 1 |
| FY2026 |
€ 0,05
€ 0,03 – € 0,06
|
506,32 M | 2 |
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| 2026 Q2 |
€ 0,02
€ 0,01 – € 0,02
|
126,96 M | 2 |
| 2026 Q1 |
€ 0,01
€ 0,00 – € 0,02
|
109,22 M | 2 |
Winstverassingen
Laatste 4 kwartalen
| Kwartaal | Geschat WPA | Werkelijk WPA | Verrassing |
|---|---|---|---|
| Q42025 | € 0,01 | -€ 0,01 | -207,0% |
| Q32025 | € 0,01 | -€ 0,01 | -167,0% |
| Q22025 | -€ 0,01 | -€ 0,02 | -73,0% |
| Q12025 | N/A | -€ 0,02 | — |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 170,43% | Revenue Growth (3Y) | 74,63% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 49,06% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 268,77 M | Net Income (TTM) | -68,11 M |
| ROE | -26,46% | ROA | -10,18% |
| Gross Margin | 47,29% | Operating Margin | -0,39% |
| Net Margin | -25,34% | Free Cash Flow (TTM) | -24,61 M |
| ROIC | -0,19% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1,31 |
| Interest Coverage | N/A | Asset Turnover | 0,40 |
| Working Capital | 73,06 M | Tangible Book Value | 59,36 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -6,39 | Forward P/E | 4,34 |
| P/B Ratio | 1,77 | P/S Ratio | 1,62 |
| PEG Ratio | N/A | Forward PEG | 0,04 |
| EV/EBITDA | 28,92 | Fwd EV/EBITDA | N/A |
| Forward P/S | 0,86 | Fwd Earnings Yield | 23,04% |
| FCF Yield | -5,65% | ||
| Market Cap | 435,51 M | Enterprise Value | 435,51 M |
| Per Share | |||
| EPS (Diluted TTM) | -0,09 | Revenue / Share | 0,25 |
| FCF / Share | -0,02 | OCF / Share | 0,00 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 10,54% | FCF Conversion | 36,13% |
| SBC-Adj. FCF | -35,54 M | Growth Momentum | 121,37 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 268,77 M | 99,38 M | 88,13 M | 74,63 M | 54,45 M |
| Net Income | -68,11 M | -28,01 M | -25,55 M | -42,46 M | -33,69 M |
| EPS (Diluted) | -0,09 | -0,16 | -0,19 | -0,33 | -0,27 |
| Gross Profit | 127,10 M | 50,77 M | 44,10 M | 30,91 M | 19,80 M |
| Operating Income | -1,05 M | 13,56 M | 10,58 M | -6,94 M | -20,48 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | — | — | — | — |
| SG&A Expenses | 81,19 M | 28,06 M | 28,22 M | 33,82 M | 33,66 M |
| D&A | 16,11 M | 2,54 M | 2,87 M | 3,34 M | 3,03 M |
| Interest Expense | — | 31,19 M | 31,26 M | 22,59 M | 10,58 M |
| Income Tax | 28,23 M | 11,11 M | 7,72 M | 5,89 M | 4,12 M |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 817,15 M | 278,86 M | 183,26 M | 159,16 M | 166,97 M |
| Total Liabilities | 509,73 M | 223,30 M | 199,31 M | 155,72 M | 123,96 M |
| Shareholders' Equity | 307,42 M | 55,56 M | -16,04 M | 3,44 M | 43,01 M |
| Total Debt | — | — | — | 58,03 M | 27,33 M |
| Cash & Equivalents | — | — | — | — | — |
| Current Assets | 305,11 M | 230,37 M | 148,85 M | 46,73 M | 41,64 M |
| Current Liabilities | 191,53 M | 135,47 M | 179,47 M | 29,71 M | 16,41 M |
{"event":"ticker_viewed","properties":{"ticker":"VREOF","listing_kind":"stock","pathname":"/stocks/vreof","exchange":"OTC","country":"US"}}